Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kaiser

Showing results (151-160 of 206) with videos related to

Pageof 21
Sort By:
Leukemia|August 10, 2021
Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugsJ R Jones, A Barber, Y-V Le Bihan, et al.
Blood|April 16, 2014
Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcomeAnnamaria Brioli, Hannah Giles, Charlotte Pawlyn, et al.
Blood Cancer Journal|July 17, 2025
Whole body MRI by MY-RADS for imaging response assessment in multiple myelomaChristina Messiou, Nuria Porta, Dow-Mu Koh, et al.
Blood|December 6, 2021
Redefining nonmeasurable multiple myeloma using mass spectrometryHannah V Giles, Mark A Cook, Mark Trehane Drayson, et al.
Optics Express|December 14, 2016
High quality entanglement on a chip-based frequency combF Mazeas, M Traetta, M Bentivegna, et al.
Radiology. Imaging Cancer|September 24, 2021
Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with MyelomaChristina Messiou, Nuria Porta, Bhupinder Sharma, et al.
Blood|August 23, 2017
Neutral tumor evolution in myeloma is associated with poor prognosisDavid C Johnson, Oleg Lenive, Jonathan Mitchell, et al.
Leukemia|February 1, 2014
Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myelomaL Melchor, A Brioli, C P Wardell, et al.
Haematologica|June 7, 2021
Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patientsNiels Weinhold, Hans J Salwender, David A Cairns, et al.
British Journal of Haematology|December 21, 2022
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trialMatthew W Jenner, Charlotte Pawlyn, Faith E Davies, et al.
Pageof 21

Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Leukemia|August 10, 2021
Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugsJ R Jones, A Barber, Y-V Le Bihan, et al.
Blood|April 16, 2014
Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcomeAnnamaria Brioli, Hannah Giles, Charlotte Pawlyn, et al.
Blood Cancer Journal|July 17, 2025
Whole body MRI by MY-RADS for imaging response assessment in multiple myelomaChristina Messiou, Nuria Porta, Dow-Mu Koh, et al.
Blood|December 6, 2021
Redefining nonmeasurable multiple myeloma using mass spectrometryHannah V Giles, Mark A Cook, Mark Trehane Drayson, et al.
Optics Express|December 14, 2016
High quality entanglement on a chip-based frequency combF Mazeas, M Traetta, M Bentivegna, et al.
Radiology. Imaging Cancer|September 24, 2021
Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with MyelomaChristina Messiou, Nuria Porta, Bhupinder Sharma, et al.
Blood|August 23, 2017
Neutral tumor evolution in myeloma is associated with poor prognosisDavid C Johnson, Oleg Lenive, Jonathan Mitchell, et al.
Leukemia|February 1, 2014
Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myelomaL Melchor, A Brioli, C P Wardell, et al.
Haematologica|June 7, 2021
Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patientsNiels Weinhold, Hans J Salwender, David A Cairns, et al.
British Journal of Haematology|December 21, 2022
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trialMatthew W Jenner, Charlotte Pawlyn, Faith E Davies, et al.
Pageof 21